Regulatory Strategies and Challenges for Neglected Infectious Diseases of High Medical Impact but Low Commercial Value: The Case of the Medicines for Malaria Venture

03 Dec 2001

Robert G Riddley and David Ubben

The Regulatory Affairs Journal

Article in Regulatory Affairs Journal

Attachments

Download this article [406.79 KB]

pdf - 406.79 KB